Tag:
GI Dynamics
Latest Headlines
Latest Headlines
GI Dynamics' EndoBarrier implanted in first patients, stock soars
GI Dynamics ($GID) has announced that the first patients have undergone treatment in Australia with the company's EndoBarrier therapy, which is used to treat obesity and Type 2 diabetes.
Obesity startup Obalon pulls in $1.5M
Obesity treatment device startup Obalon Therapeutics has raised $1.5 million to continue ongoing work.
Report: Device industry sees solid performance in 2010, but challenges remain
Ernst and Young released its report this week in conjunction with AdvaMed's annual meeting on the medical device industry's performance. It found that while the sector delivered a solid perforance
GI Dynamics starts trading on ASX
Shares in GI Dynamics have started trading on the Australian Securities Exchange under the stock symbol "GID." The company's CHESS Depositary Interests closed 17 cents below their offer price of
GI Dynamics raises $85M in Australian IPO
Lexington, MA-based GI Dynamics has raised about $85 million from its Australian IPO. The company said it would list Sept. 7 in Sydney with a market value of AU$304 million ($324.6 million), The
GI Dynamics advances weight loss advice
GI Dynamics has a fresh set of positive clinical results from three studies of its EndoBarrier Gastrointestinal Liner, a device used to treat type 2 diabetes, weight loss and other metabolic factors.
